Results 111 to 120 of about 15,332 (193)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis. [PDF]

An Bras Dermatol, 2021
Barroso DH, Gomes CM, Silva AMD, Sampaio RNR.   +3 more
europepmc   +1 more source

Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia [PDF]

, 2009
We conducted a case-control study to evaluate risk factors for visceral leishmaniasis during an epidemic in a previously unaffected district of Ethiopia. We also collected blood and bone marrow specimens from dogs in the outbreak villages.
Alvar, Jorge, Aparicio, Pilar, Argaw, Daniel, Bashaye, Seife, Bern, Caryn, Cañavate, Carmen, Chicharro, Carmen, Herrero, Merce, Mulugeta, Abate, Nieto, Javier, Nombela, Nohelly, Vélez, Iván Darío   +11 more
core   +1 more source

Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient. [PDF]

Head Neck Pathol, 2021
Botelho MCB, Ferreira LL, Fikaris S, Prado-Ribeiro AC, Soubhia AMP, Biasoli ER, Miyahara GI, Bernabé DG.   +7 more
europepmc   +1 more source

Custo-efetividade de estratégias de prevenção contra a leishmaniose tegumentar americana na Argentina [PDF]

, 2013
The aim of this study was to estimate the cost-effectiveness of reducing tegumentary leishmaniasis transmission using insecticide-impregnated clothing and curtains, and implementing training programs for early diagnosis.
Orellano, Pablo Wenceslao, Salomon, Oscar Daniel, Vazquez, Néstor   +2 more
core   +1 more source

Advances in leishmaniasis.

, 2005
Governed by parasite and host factors and immunoinflammatory responses, the clinical spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).
Berman, Jonathan D, Davies, Clive R, Murray, Henry W, Saravia, Nancy G   +3 more
core   +1 more source

Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina. [PDF]

PLoS Negl Trop Dis, 2021
García-Bustos MF, González-Prieto G, Paniz-Mondolfi AE, Parodi C, Beckar J, Monroig S, Ramos F, Mora MC, Delgado-Noguera LA, Hashiguchi Y, Jaime D, Moreno S, Ruiz-Morales L, Lemir CG, Barrio A.   +14 more
europepmc   +1 more source

Influence of Leishmania (Viannia) Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis [PDF]

, 2017
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary leishmaniasis (ATL). There are, however, reports of the occurrence of treatment failure with these drugs.
Adaui, Vanessa, Arevalo, Jorge, Chappuis, Francois, De Doncker, Simonne, Dujardin, Jean-Claude, Lazo, Marcela, Llanos-Cuentas, Alejandro, Loayza-Muro, Raúl, Maurer, Anne, Miranda-Verástegui, César, Ramirez, Luis, Tulliano, Gianfranco, Zimic, Mirko   +12 more
core  

Application of magnetically induced hyperthermia on the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections

, 2012
Magnetic hyperthermia is currently an EU-approved clinical therapy against tumor cells that uses magnetic nanoparticles under a time varying magnetic field (TVMF).
Asín, L., Goya, G. F., Grazú, V., Ibarra, M. R., Marquina, C., Moros, M., Silber, A. M., Torres, T. E.   +7 more
core   +1 more source

Cytokine Networks and the Clinical Outcome of American Teg-Umentary Leishmaniasis: Unveiling Targets for Alternative Therapeutic Interventions

Pathogens
American Tegumentary Leishmaniasis (ATL), caused by parasites of the genus Leishmania, presents a significant global health challenge, especially in Brazil, where cutaneous and mucosal forms are highly prevalent.
Carolina Cattoni Koh, Kenneth J. Gollob, Walderez O. Dutra   +2 more
doaj   +1 more source

Diversity and Species Composition of Sand Flies (Diptera: Psychodidae) in a Venezuelan Urban Focus of Cutaneous Leishmaniasis [PDF]

, 2004
Volume ...

core